Drug teratogenicity refers to the potential of certain medications to cause developmental abnormalities or congenital malformations in a developing fetus when taken during pregnancy. Understanding and identifying teratogenic risks is crucial for healthcare providers to ensure the safety of pregnant patients and to prevent adverse birth outcomes.

Drug Teratogenicity

Developmental Abnormalities

Congenital malformations are structural or functional anomalies that occur during intrauterine life and can be identified prenatally, at birth, or later in life. They can result from genetic factors, environmental influences, or a combination of both, and can vary widely in severity and impact on health.

Congenital Malformations

Developing fetus

Teratogenic risks

Healthcare Providers

Safety of pregnant patients

Adverse birth outcomes refer to complications during pregnancy or childbirth that negatively affect the health of the mother, fetus, or newborn, including preterm birth, low birth weight, and stillbirth. These outcomes can result from various factors such as maternal health conditions, environmental exposures, and socioeconomic factors, and they have significant implications for long-term health and development.

Concepts

Relevant Degrees

Your Lessons